Prøve GULL - Gratis
The Campaign Goldman's CEO Waged to Silence Powerful Internal Critics
Mint Ahmedabad
|May 28, 2025
David Solomon was under siege from partners critical of his leadership; the firm launched a probe to identify leakers
David Solomon was fed up with his critics inside Goldman Sachs. The time had come to crack down.
It was bad enough that Goldman partners were criticizing the chief executive's leadership and bad-mouthing the storied bank's costly expansion of consumer lending. What rankled Solomon even more was the suspicion that some of the naysayers were leaking details to reporters. Goldman launched a probe to figure out who was talking, according to people familiar with the probe.
Solomon was going through a brutal stretch in 2022 and 2023. The consumer lending expansion that he had spearheaded was generating billions of dollars in losses. It was hurting Goldman's stock, moneymaking partners were leaving, and Solomon had taken flak for his attention-grabbing side gig DJing.
Solomon told Goldman's board that he was going to take action, pushing out troublemakers who he said were undermining him with their leaks, people familiar with the matter said. The board told Solomon he had their support. By last year, longtime executives who had openly criticized his strategy were gone. The departures sent a message inside Goldman: No one is safe if they go up against the CEO.
These days, things are going a whole lot smoother for Solomon. The bank is exiting consumer lending and refocusing on its core businesses of advising giant companies and wealthy individuals. Solomon gave up the prominent DJ gigs. Profits have been rising steadily. In February, Goldman's stock hit a record high.
And Solomon, 63 years old, has cemented control for the foreseeable future. This year, he got a 26% raise and an $80 million bonus to stay for five more years.
This account of Solomon's comeback is based on conversations with current and former Goldman partners and executives, many of whom interacted directly with Solomon over the period.
Denne historien er fra May 28, 2025-utgaven av Mint Ahmedabad.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Ahmedabad
Mint Ahmedabad
'If you're on trend, you are in trouble'
Patou creative head Guillaume Henry discusses the essence of couture and why simple is best
4 mins
December 13, 2025
Mint Ahmedabad
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Ahmedabad
Chair man, of the bored
STREAM OF STORIES
3 mins
December 13, 2025
Mint Ahmedabad
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Ahmedabad
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Ahmedabad
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Ahmedabad
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Ahmedabad
How 'puri-aloo' and 'chaat' unite Lucknow
Whenever my friends want to eat puri-aloo, they invite themselves over to my home.
5 mins
December 13, 2025
Mint Ahmedabad
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Ahmedabad
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
1 mins
December 13, 2025
Listen
Translate
Change font size
